QMS Medical Allied Services Fund Raise of ₹12.05 Cr

QMS Medical Allied Services Annual General Meeting

QMS Medical Allied Services Limited held its 9th Annual General Meeting on September 30, 2026. Shareholders approved a 5% final dividend and adoption of financial results.

QMS Medical Allied Services Acquisition

QMS Medical Allied Services Limited is acquiring BeamOptics Scientific Private Limited. The strategic acquisition aims to expand the company's addressable market in healthcare business.

Execution

on or before 30th November, 2027

QMS Medical Allied Services Business Update

QMS Medical Allied Services executed a shareholders' agreement with investors and its subsidiary, Saarathi Healthcare, defining governance rights, veto powers, and share transfer restrictions.

QMS Medical Allied Services Merger & Restructuring

QMS Medical Allied Services Limited approved a composite demerger scheme for its healthcare business and the acquisition of a 100% stake in BeamOptics Scientific Private Limited.

QMS Medical Allied Services Acquisition Worth ₹14.22 Cr

QMS Medical Allied Services Ltd acquired the remaining 24% stake in Saarathi Healthcare Private Limited for Rs. 14.23 Crore, making it a wholly-owned subsidiary.

Value

₹14.22 Cr

QMS Medical Allied Services Other Announcement

QMS Medical Allied Services Limited informed the exchange regarding the dispatch of annual report links to shareholders who haven't registered their email addresses.

Rajkot Investment Trust Fund Raise of ₹48 Cr

Rajkot Investment Trust's board approved a Rs 48 Crore rights issue of equity shares. Pricing and record date will be set later by a committee.

Value

₹48.00 Cr

U Y Fincorp Fund Raise of ₹187.2 Cr

U.Y. Fincorp's board approved preferential issues of warrants and equity shares aggregating Rs 187.17 Crore. The issue is subject to shareholder and regulatory approvals.

Value

₹187.2 Cr

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026